Doxycycline in mitochondrial mediated pathway of apoptosis: A systematic review

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 7, 2010, Pages 556-563

  Sagar, Jayesh ^a,b   Sales, Kevin ^a   Seifalian, A ^a,b   Winslet, M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; Caspase independent apoptosis; Caspases; Doxcycline; Mitochondria

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DOXYCYCLINE; ENDONUCLEASE G; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAX; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; CELL VIABILITY; DATA EXTRACTION; DRUG ACTIVITY; DRUG CYTOTOXICITY; EMBASE; MEDLINE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TOXICITY; MITOCHONDRION; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; SYSTEMATIC REVIEW;

EID: 78649856359     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010793498645     Document Type: Article

References (31)

1. Smilack, J. D. The tetracyclines. Mayo Clin. Proc., 1999, 74, 727-729.
2. Ryan, M. E.; Greenwald, R. A.; Golub, L. M. Potential of tetracyclinesto modify cartilage breakdown in osteoarthritis. Curr. Opin.Rheumatol., 1996, 8, 238-247.
3. Curci, J. A.; Petrinec, D.; Liao, S.; Golub, L. M.; Thompson, R. W.Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modifiedtetracyclines. J. Vasc. Surg., 1998, 28, 1082-1093.
4. Petrinec, D.; Liao, S.; Holmes, D. R.; Reilly, J. M.; Parks, W. C.; Thompson, R. W. Doxycycline inhibition of aneurysmal degenerationin an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed productionof 92 kD gelatinase. J. Vasc. Surg., 1996, 23, 336-346.
5. Fenton, K. N.; Richardson, J. D. Diagnosis and management of malignant pleural effusions. Am. J. Surg., 1995, 170, 69-74.
6. Smith, J. R.; Gabler, W. L. Protective effects of doxycycline inmesenteric ischemia and reperfusion. Res. Commun. Mol. Pathol.Pharmacol., 1995, 88, 303-315.
7. Fife, R. S.; Sledge, G. W. Jr.; Roth, B. J.; Proctor, C. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett., 1998, 127, 37-41.
8. Lokeshwar, B. L.; Selzer, M. G.; Zhu, B. Q.; Block, N. L.; Golub, L. M. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int. J. Cancer, 2002, 98, 297-309.
9. Seftor, R. E.; Seftor, E. A.; De Larco, J. E.; Kleiner, D. E.; Leferson, J.; Stetler-Stevenson, W. G.; et al.: Chemically modified tetracyclinesinhibit human melanoma cell invasion and metastasis.Clin. Exp. Metastasis, 1998, 16, 217-225.
10. Cakir, Y.; Hahn, K. A. Direct action by doxycycline against canineosteosarcoma cell proliferation and collagenase (MMP-1) activityin vitro. In Vivo, 1999, 13, 327-331.
11. Duivenvoorden, W. C.; Popovic, S.; Lhotak, S.; Seidlitz, E.; Hirte, H. W.; Tozer, R. G.; Singh, G. Doxycycline decreases tumor burdenin a bone metastasis model of human breast cancer. CancerRes., 2002, 62, 1588-1591.
12. Fife, R. S.; Sledge, G. W. Jr. Effects of doxycycline on in vitrogrowth, migration, and gelatinase activity of breast carcinoma cells.J. Lab. Clin. Med., 1995, 125, 407-411.
13. Iwasaki, H.; Inoue, H.; Mitsuke, Y.; Badran, A.; Ikegaya, S.; Ueda, T. Doxycycline induces apoptosis by way of caspase-3 activationwith inhibition of matrix metalloproteinase in humanT-lymphoblastic leukemia CCRF-CEM cells. J. Lab. Clin. Med., 2002, 140, 382-386.
14. Gu, Y.; Lee, H. M.; Roemer, E. J.; Musacchia, L.; Golub, L. M.; Simon, S. R. Inhibition of tumor cell invasiveness by chemicallymodified tetracyclines. Curr. Med. Chem., 2001, 8, 261-270.
15. Ichikawa, Y.; Ishikawa, T.; Tanaka, K.; Togo, S.; Shimada, H.Extracellular matrix degradation enzymes: important factors inliver metastasis of colorectal cancer and good targets for anticancermetastatic therapy. Nippon Geka Gakkai Zasshi, 2001, 102, 376-380.
16. Mouratidis, P. X.; Colston, K. W.; Dalgleish, A. G. Doxycyclineinduces caspase-dependent apoptosis in human pancreatic cancercells. Int. J. Cancer, 2007, 120, 743-752.
17. Onoda, T.; Ono, T.; Dhar, D. K.; Yamanoi, A.; Nagasue, N. Tetracyclineanalogues (doxycycline and COL-3) induce caspasedependentand -independent apoptosis in human colon cancer cells.Int. J. Cancer, 2006, 118, 1309-1315.
18. Liu, J.; Kuszynski, C. A.; Baxter, B. T. Doxycycline inducesFas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes.Biochem. Biophys. Res. Commun., 1999, 260, 562-567.
19. Kerr, J. F.; Wyllie, A. H.; Currie, A. R. Apoptosis: a basic biologicalphenomenon with wide-ranging implications in tissue kinetics.Br. J. Cancer, 1972, 26, 239-257.
20. Hengartner, M.O. The biochemistry of apoptosis. Nature, 2000, 407, 770-776.
21. Kaufmann, S. H.; Hengartner, M.O. Programmed cell death: aliveand well in the new millennium. Trends Cell Biol., 2001, 11, 526-534.
22. Schwartz, L. M.; Smith, S.W.; Jones, M. E.; Osborne, B. A. Do allprogrammed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci.USA, 1993, 90, 980-984.
23. Sourdeval, M.; Lemaire, C.; Brenner, C.; Boisvieux-Ulrich, E.; Marano, F. Mechanisms of doxycycline-induced cytotoxicity onhuman bronchial epithelial cells. Front. Biosci., 2006, 11, 3036-3048.
24. Wu, J.; Liu, T.; Xie, J.; Xin, F.; Guo, L. Mitochondria and calpainsmediate caspase-dependent apoptosis induced by doxycycline inHeLa cells. Cell. Mol. Life Sci., 2006, 63, 949-957.
25. Yeh, Y. C.; Lai, H. C.; Ting, C. T.; Lee, W. L.; Wang, L. C.; Wang, K. Y.; Lai, H. C.; Liu, T. J. Protection by doxycyclineagainst doxorubicin-induced oxidative stress and apoptosis inmouse testes. Biochem. Pharmacol., 2007, 74, 969-980.
26. Sagar, J.; Sales, K.; Dijk, S.; Taanman, J.; Seifalian, A.; Winslet, M. Does doxycycline work in synergy with cisplatin and oxaliplatinin colorectal cancer? World J. Surg. Oncol., 2009, 7, 2.
27. Dong, Z.; Saikumar, P.; Weinberg, J. M.; Venkatachalam, M. A.Calcium in cell injury and death. Annu. Rev. Pathol., 2006, 1, 405-434.
28. Li, L. Y.; Luo, X.; Wang, X. Endonuclease G is an apoptoticDNase when released from mitochondria. Nature, 2001, 412, 95-99.
29. Miramar, M. D.; Costantini, P.; Ravagnan, L.; Saraiva, L. M.; Haouzi, D.; Brothers, G.; Penninger, J. M.; Peleato, M. L.; Kroemer, G.; Susin, S. A. NADH oxidase activity of mitochondrialapoptosis-inducing factor. J. Biol. Chem., 2001, 276, 16391-16398.
30. Saelens, X.; Festjens, N.; Vande, W. L.; van Gurp, M.; van Loo, G.; Vandenabeele, P. Toxic proteins released from mitochondria incell death. Oncogene, 2004, 23, 2861-2874.
31. Nam, D. H.; Lee, K. S.; Kim, S. H.; Kim, S. M.; Jung, S. Y; Chung, S. H.; Kim, H. J.; Kim, N. D.; Jin, C.; Lee, Y. S. Design and synthesisof 4-quinolinone 2-carboxamides as calpain inhibitors.Bioorg. Med. Chem. Lett., 2008, 18, 205-9.